FDA approves new treatment for uncomplicated urinary tract infections
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 The US Food and Drug Administration (FDA) yesterday approved the oral antibiotic pivmecillinam for treating uncomplicated urinary tract infections (uUTIs). Marketed under the brand name Pivya, pivmecillinam has a unique mechanism of action but is not a new antibiotic. In fact, it has been used outside of the United States to treat uUTIs for more than 40 years and is recommended as a first-line treatment in several countries. But it’s the